Interestingly, in an adult model of stroke using middle cerebral artery occlusion, a small dose of Tat-Beclin1 (1.5 mg/kg) given i.p. at 6 and 13 days after injury worsened the neurological deficit and increased infarct volumes [37]. This evidence concerns the gene TAT and Stroke.